# A Phase I Study of Lipovaxin Tuberculosis Vaccine in Adult Healthy Populations

> **NCT07647107** · PHASE1 · NOT_YET_RECRUITING · sponsor: **PT Bio Farma** · enrollment: 60 (estimated)

## Conditions studied

- Tuberculosis
- TB Infection

## Interventions

- **BIOLOGICAL:** LipovaxinS4-EAH (Middle Dose)
- **BIOLOGICAL:** LipovaksinS4-EAH (High Dose)
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT07647107
- **Lead sponsor:** PT Bio Farma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2027-07
- **Final completion:** 2027-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-06-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07647107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07647107, "A Phase I Study of Lipovaxin Tuberculosis Vaccine in Adult Healthy Populations". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07647107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*